A Study of a Baby Wash/Shampoo and Baby Lotion Versus Baby Wash/Shampoo Alone for Impact on Skin Barrier and Microbiome on Newborns

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-25

Study Completion Date

2023-06-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate the tolerance of a baby wash/shampoo alone and the tolerance of a regimen of a baby wash/shampoo and baby lotion in a newborn population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of a Whole-Body Balm on Newborn Babies

NCT05786209

Healthy

COMPLETED NA

A Clinical Assessment of the Efficacy and Effects of Different Skincare Regimens on Infants

NCT02981056

Baby Skin Development

COMPLETED NA

Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.

NCT03457857

Microbiome

COMPLETED NA

Safety Study of Infant Formula With Partially Hydrolized Whey

NCT00548106

Growth Failure

WITHDRAWN NA

Evaluation of the Efficacy of an Amino Acid Based Formula in Infants

NCT01584245

Cow's Milk Allergy

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baby Wash/Shampoo

Parent participant will bathe the baby participants using baby wash/shampoo at least 3 times per week, but no more than once daily, up to 4 weeks.

Group Type EXPERIMENTAL

Baby Wash/Shampoo

Intervention Type OTHER

Parent participant will bathe the baby participant with the baby wash/shampoo at least 3 times per week, but no more than once daily.

Baby Wash/Shampoo + Baby Lotion

Parent participant will bathe the baby participants using baby wash/shampoo at least 3 times per week, but no more than once daily, and apply lotion at least once daily after bathing, for 4 weeks.

Group Type EXPERIMENTAL

Baby Wash/Shampoo

Intervention Type OTHER

Parent participant will bathe the baby participant with the baby wash/shampoo at least 3 times per week, but no more than once daily.

Baby Lotion

Intervention Type OTHER

Parent participant will use the baby lotion on baby participants at least once daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Baby Wash/Shampoo

Parent participant will bathe the baby participant with the baby wash/shampoo at least 3 times per week, but no more than once daily.

Intervention Type OTHER

Baby Lotion

Parent participant will use the baby lotion on baby participants at least once daily.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For Baby and Parent:

* Baby medically determined to be in overall good health and eligible for study participation. Parent determined to be in generally good health and able to participate fully in the study

For Baby only:

* Healthy, full-term, newborns 0 - 28 days old at start of study, (both vaginal and Caesarean mode of delivery may be included, 37+ weeks gestation)
* Fitzpatrick Skin Types I - VI

For Parent only:

* 18 years of age or older
* Biological, legal guardian and primary caregiver of the baby participant (must be able to present proof of guardianship \[that is, birth certificate along with valid identification {ID} of parent, hospital records, insurance card, et cetera {etc.}\])
* Able to read, write, speak, and understand english
* Has signed the informed consent document (ICD) including Health Insurance Portability and Accountability Act (HIPAA) disclosure
* Has to have access to internet to be able to complete questionnaires and diaries
* Intends to successfully complete the study and is willing and able to follow the participant responsibilities

Exclusion Criteria

For Baby and Parent:

* Has known allergies or adverse reactions to common topical skincare products or ingredients in the investigational study materials
* Has self-reported Type 1 or Type 2 diabetes or is taking insulin or another anti-diabetic medication
* Is taking medications that would mask an adverse event (AE) or influence the study results, including: immunosuppressive and steroidal drugs within 3 months before Visit 1 and during the study; non-steroidal anti-inflammatory drugs within 5 days before Visit 1 and during the study; antihistamines within 2 weeks before Visit 1 and during the study; systemic or topical over-the-counter (OTC) or prescription medications that, in the principle investigator (PI)'s judgement, will affect skin condition or interfere with study evaluation (example, antibiotics). Use of acetaminophen as needed is acceptable if it was instructed by the baby's pediatrician. Child vitamins are allowed
* Has a history of or a concurrent health condition/situation which, in the opinion of the PI, may put the individual at significant risk, confound the study results, or interfere significantly with the individual's participation in the study
* Is simultaneously participating in any other type of study or has participated in a study within the past 14 days
* Is an employee/contractor or immediate family member of the PI, study site or sponsor

For Baby only:

* Presents with a skin condition that may influence the outcome of the study (example, psoriasis, eczema, atopic dermatitis, cutaneous xerosis, erythema, or active skin cancer)
* Either biological parent or a sibling has clinically determined atopic dermatitis or asthma
* Clinical grade greater than 0 for rash/irritation or greater or equal to 1 for any of the other clinically assessed parameters

For Parent only:

* Is self-reported to be pregnant or planning to become pregnant during the study

Minimum Eligible Age

0 Days

Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes